Literature DB >> 9009184

Help from within for damaged axons.

Y A Barde.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9009184     DOI： 10.1038/385391a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses.

Authors:  Elena Gonzalez-Rey; Amelia Fernandez-Martin; Alejo Chorny; Javier Martin; David Pozo; Doina Ganea; Mario Delgado
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.

Authors:  Ruth Arnon; Rina Aharoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-15       Impact factor: 11.205

3.  Leuprolide acetate, a GnRH agonist, improves experimental autoimmune encephalomyelitis: a possible therapy for multiple sclerosis.

Authors:  Irene Guzmán-Soto; Eva Salinas; Irma Hernández-Jasso; J Luis Quintanar
Journal:  Neurochem Res       Date:  2012-07-26       Impact factor: 3.996

4.  Neurotrophins support the development of diverse sensory axon morphologies.

Authors:  S I Lentz; C M Knudson; S J Korsmeyer; W D Snider
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

5.  Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.

Authors:  Rina Aharoni; Basak Kayhan; Raya Eilam; Michael Sela; Ruth Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

6.  Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

Authors:  M Kerschensteiner; E Gallmeier; L Behrens; V V Leal; T Misgeld; W E Klinkert; R Kolbeck; E Hoppe; R L Oropeza-Wekerle; I Bartke; C Stadelmann; H Lassmann; H Wekerle; R Hohlfeld
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

Review 7.  Glatiramer in the treatment of multiple sclerosis.

Authors:  Syed A Rizvi; Edward Kim; Jennifer Moodie
Journal:  Int J Nanomedicine       Date:  2006
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.